DKV Seguros wins euro100m hospitals project:
This article was originally published in Clinica
Hospital development projects worth euro96.64m ($126m) are part of a healthcare services contract secured by Spanish insurance company DKV Seguros and two banks in Spain's Valencia region. Marina Salud, a joint venture between DKV Seguros (the Spanish subsidiary of German insurance company Deutsche Krankenversicherung, part of the ERGO group), Bancaja and Caja de Ahorros del Mediterra neo, will operate the Healthcare Area No 12 of the Comunidad Valenciana region for a period of 15 years, with an option to extend this by a further five. The contract envisages the construction of a hospital in Denia and the refurbishment of two clinics. The new hospital will feature operating theatres, 45 intensive care units, 10 haemodialysis posts and 10 outpatient surgeries.
You may also be interested in...
Public Company Edition: Lixte’s small uplisting was the only biopharma initial public offering in the US during Thanksgiving week, but IPOs are ramping up again. Also, LifeSci launched its second SPAC and in follow-on offerings Reata brought in $281m and Intellia grossed $175m.
Orladeyo is the first oral prophylactic approved in the US for hereditary angioedema, with Japan and EU approvals expected to follow. Pricing of $485,000 a year undercuts segment leader.
Results of Study to Assess Statin Residual Risk with Epanova in High Cardiovascular Risk Patients with Hypertriglyceridemia “should prompt reconsideration of [OTC] mixed omega-3 fatty acid products for [atherosclerotic cardiovascular disease] prevention,” say cardiologists in an editorial published with JAMA study.